| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/15/2011 | WO2011112070A2 A composition to boost and enhance immune system and method of preparing thereof |
| 09/15/2011 | WO2011111787A1 Cell preparation containing mesenchymal stem cells, and method for producing same |
| 09/15/2011 | WO2011111783A1 Agent for controlling the increase and decrease of lactobacillus bifidus in colon |
| 09/15/2011 | WO2011111734A1 Lactic acid bacterium-containing preparation |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111707A1 Allergy inhibitor |
| 09/15/2011 | WO2011110918A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 09/15/2011 | WO2011110575A1 Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases |
| 09/15/2011 | WO2011109877A1 Heparan sulfate replacement therapy |
| 09/15/2011 | WO2011059836A3 T cell receptor-deficient t cell compositions |
| 09/15/2011 | WO2011053653A3 Prevotella histicola preparations and the treatment of autoimmune conditions |
| 09/15/2011 | WO2011031554A3 Heterocyclic compounds as janus kinase inhibitors |
| 09/15/2011 | US20110224275 Inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224239 Combinations Comprising a S1P Receptor Agonist and a JAK3 Kinase Inhibitor |
| 09/15/2011 | US20110224225 Inhibitors of protein kinases |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 09/15/2011 | US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224171 Inhibitors of fatty acid amide hydrolase |
| 09/15/2011 | US20110224162 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity of the inflammatory response |
| 09/15/2011 | US20110224160 Use of Escin for Treatment of Type IV Hypersensitivity Reaction |
| 09/15/2011 | US20110224158 Esterified alpha-galactosylceramide |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223242 Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors |
| 09/15/2011 | US20110223230 Hydrogel formulations |
| 09/15/2011 | US20110223208 Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| 09/15/2011 | US20110223201 Immunonanotherapeutics Providing a Th1-Biased Response |
| 09/15/2011 | US20110223200 Novel compositions and methods |
| 09/15/2011 | US20110223199 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
| 09/15/2011 | US20110223198 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
| 09/15/2011 | US20110223197 Mucosal and Systemic Immunization with Alphavirus Replicon Particles |
| 09/15/2011 | US20110223196 Hiv/siv vaccines for the generation of mucosal and systemic immunity |
| 09/15/2011 | US20110223195 Composition comprising chitosan for ocular administration of vaccine(s) to avians |
| 09/15/2011 | US20110223194 Vaccine |
| 09/15/2011 | US20110223188 Targeted costimulatory polypeptides and methods of use to treat cancer |
| 09/15/2011 | US20110223187 Live listeria-based vaccines for central nervous system therapy |
| 09/15/2011 | US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response |
| 09/15/2011 | US20110223178 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/15/2011 | US20110223168 Ligand that has binding specificity for il-4 and/or il-13 |
| 09/15/2011 | US20110223165 Humanized C-Kit Antibody |
| 09/15/2011 | US20110223164 Binding domain-immunoglobulin fusion proteins |
| 09/15/2011 | US20110223145 Immunosuppressive blood cells and methods of producing the same |
| 09/15/2011 | US20110223136 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223107 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/15/2011 | US20110220265 Preparation for External Use |
| 09/15/2011 | CA2792802A1 Cell preparation containing mesenchymal stem cells, and method for producing same |
| 09/15/2011 | CA2792679A1 A novel mucosal vaccination approach for herpes simplex virus type-2 |
| 09/15/2011 | CA2792610A1 Heparan sulfate replacement therapy |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2792343A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 09/15/2011 | CA2791417A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/14/2011 | EP2364998A1 Antibodies against HMGB1 and fragments thereof |
| 09/14/2011 | EP2364997A2 Polypeptide variants with altered effector function |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364975A1 Novel amide derivative and use thereof as medicine |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364727A2 Molecular antigen array |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2275441A9 High affinity HIV T cell receptors |
| 09/14/2011 | EP1961734B1 Amine compound and use thereof for medical purposes |
| 09/14/2011 | EP1904054B1 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
| 09/14/2011 | EP1445264B1 Substance specific to pd-1 |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN1561345B Antibodies to VLA-1 |
| 09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102186842A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 09/14/2011 | CN102186501A Pharmaceutical product for up-dosing of allergy vaccine |
| 09/14/2011 | CN102186494A Whey and thymus function |
| 09/14/2011 | CN102186486A Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus |
| 09/14/2011 | CN102186479A Aminopyrimidine inhibitors of histamine receptors for the treatment of disease |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 09/14/2011 | CN102180985A Method for extracting and purifying mugwort polysaccharides |
| 09/14/2011 | CN102180960A Induction method of massive individualized natural interferon |
| 09/14/2011 | CN102180950A Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102178956A Preparation, medical application and composition of 20S-protopanaxadiol beta-cyclodextrin inclusion compound |
| 09/14/2011 | CN102178955A Idiotoxin solvent and preparation method thereof |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN102178935A Preparation for resisting radiation, enhancing body immunity and preventing and treating tumors |
| 09/14/2011 | CN102178934A Preparation for increasing bone mineral density, preventing osteoarthrosis and enhancing immunity |
| 09/14/2011 | CN102178932A Preparation for relieving fatigue and enhancing immunity |
| 09/14/2011 | CN102178931A Recombinant human interleukin-12 preparation for injection and preparation method thereof |
| 09/14/2011 | CN102178913A Skin care pill for treating cold sensitive disease and preparation method thereof |
| 09/14/2011 | CN102178848A Traditional Chinese medicinal dendrobium officinale preparation and preparation method thereof |
| 09/14/2011 | CN102178847A Vacuum freeze-drying processing method of dendrobium officinale |
| 09/14/2011 | CN102178839A Pharmaceutical composition for treating blood deficiency and preparation method thereof |
| 09/14/2011 | CN102178791A Toxin expelling and acne removing agent and preparation method and use method thereof |
| 09/14/2011 | CN102178763A Medicament for treating anaphylactoid purpura |
| 09/14/2011 | CN102178737A Medicament for immunological and allergic diseases |